SOHM Files Provisional Patent on ABBIE's 'Smart Gene-Editing' That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations -January 09, 2024 at 09:31 am EST
CHINO HILLS, Calif., Jan. 09, 2024 -- via IBN -- SOHM, Inc. , a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and markets generic drugs covering numerous...
Source: marketscreener.com